ABOVE: © ISTOCK.COM, HORKINS
Last Wednesday (September 4), Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research, which will focus on using psychedelic compounds such as LSD, ketamine, and psilocybin to treat mental health problems. The center, founded with $17 million in donations, is the first of its kind in the US, according to The New York Times. It follows the opening of Imperial College London’s psychedelic treatment center in April 2019.
“The center’s establishment reflects a new era of research in therapeutics and the mind through studying this unique and remarkable class of pharmacological compounds,” says center director and neurologist Roland Griffiths in a press release. The use of psychedelics as treatment has been studied since the mid-20th century, but progress has stalled historically due to stigma, potential for abuse, and mixed research results. The new center is opening after several decades of renewed ...
